Heart Disease Trial, Recruiting (NCT04829617)

Heart Disease Trial, Recruiting NCT04829617 Sponsor: Massachusetts General Hospital Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04829617 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults who have been diagnosed with heart failure classified as mild to moderate in severity (known as NYHA Class I, II, or III).
People whose adherence to recommended health behaviours — such as following a healthy diet, exercising, and taking medications as directed — has been assessed as below a set threshold using a standard questionnaire.

Who may not be able to join:

People whose thinking or memory difficulties would make it hard for them to give informed consent or take part, as assessed by a short cognitive test.
People with a medical condition that is likely to lead to death within 6 months.
People who are unable to take part in physical activity because of another medical condition, such as arthritis.
People who are unable to read, write, or speak in English.
People who are currently taking part in another program or study designed to improve wellbeing or help with following health-related behaviours.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christopher M Celano, MD, Massachusetts General Hospital

Phone: 617-726-6485

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04829617

Sponsor: Massachusetts General Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: 617-726-6485

More information: https://clinicaltrials.gov/study/NCT04829617

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults who have been diagnosed with heart failure classified as mild to moderate in severity (known as NYHA Class I, II, or III).
People whose adherence to recommended health behaviours — such as following a healthy diet, exercising, and taking medications as directed — has been assessed as below a set threshold using a standard questionnaire.

Who may not be able to join:

People whose thinking or memory difficulties would make it hard for them to give informed consent or take part, as assessed by a short cognitive test.
People with a medical condition that is likely to lead to death within 6 months.
People who are unable to take part in physical activity because of another medical condition, such as arthritis.
People who are unable to read, write, or speak in English.
People who are currently taking part in another program or study designed to improve wellbeing or help with following health-related behaviours.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Massachusetts General Hospital

Registry

ClinicalTrials.gov

Start date

29 November 2021

Est. completion

30 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Health behavior adherence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov